Repositioning Candidate Details

Candidate ID: R0036
Source ID: DB00120
Source Type: approved; investigational; nutraceutical
Compound Type: small molecule
Compound Name: Phenylalanine
Synonyms: (S)-2-Amino-3-phenylpropionic acid; (S)-alpha-Amino-beta-phenylpropionic acid; 3-phenyl-L-alanine; beta-Phenyl-L-alanine; F; L-Phenylalanine; Phe; Phenylalanine; β-phenyl-L-alanine
Molecular Formula: C9H11NO2
SMILES: N[C@@H](CC1=CC=CC=C1)C(O)=O
Structure:
DrugBank Description: Phenylalanine is an essential aromatic amino acid that is a precursor of melanin, , (norepinephrine), and .
CAS Number: 63-91-2
Molecular Weight: 165.1891
DrugBank Indication: L-phenylalanine may be helpful in some with depression. It may also be useful in the treatment of vitiligo. There is some evidence that L-phenylalanine may exacerbate tardive dyskinesia in some schizophrenic patients and in some who have used neuroleptic drugs.
DrugBank Pharmacology: Used by the brain to produce Norepinephrine, a chemical that transmits signals between nerve cells and the brain; keeps you awake and alert; reduces hunger pains; functions as an antidepressant and helps improve memory.
DrugBank MoA: The supposed antidepressant effects of L-phenylalanine may be due to its role as a precursor in the synthesis of the neurotransmitters norepinephrine and dopamine. Elevated brain norepinephrine and dopamine levels are thought to be associated with antidepressant effects. <br/>The mechanism of L-phenylalanine's possible antivitiligo activity is not well understood. It is thought that L-phenylalanine may stimulate the production of melanin in the affected skin
Targets: Tyrosine aminotransferase; Large neutral amino acids transporter small subunit 2; Phenylalanine--tRNA ligase alpha subunit; Phenylalanine-4-hydroxylase; Phenylalanine--tRNA ligase, mitochondrial; Phenylalanine--tRNA ligase beta subunit; Tyrosine 3-monooxygenase binder
Inclusion Criteria: Indication associated